Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CDAKQ | Common Stock | Purchase | +723K | +63.21% | 1.87M | Sep 15, 2022 | By Flagship Ventures Fund V, L.P. | F1, F2 | ||
transaction | CDAKQ | Common Stock | Purchase | +211K | +21.54% | 1.19M | Sep 15, 2022 | By Flagship V VentureLabs Rx Fund, L.P. | F1, F3 | ||
holding | CDAKQ | Common Stock | 486K | Sep 15, 2022 | Flagship VentureLabs V LLC | F4 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CDAKQ | Warrants to purchase Common Stock | Purchase | +723K | 723K | Sep 15, 2022 | Common Stock | 723K | $1.88 | By Flagship Ventures Fund V, L.P. | F1, F2 | |||
transaction | CDAKQ | Warrants to purchase Common Stock | Purchase | +211K | 211K | Sep 15, 2022 | Common Stock | 211K | $1.88 | By Flagship V VentureLabs Rx Fund, L.P. | F1, F3 |
Id | Content |
---|---|
F1 | On September 15, 2022, pursuant to an underwritten public offering by the Issuer (the "Offering"), Flagship Ventures Fund V, L.P. ("Flagship Fund V") acquired 722,590 shares of Common Stock and accompanying warrants to purchase 722,590 shares of Common Stock, and Flagship V VentureLabs Rx Fund, L.P. ("Flagship Fund V Rx") acquired 210,743 shares of Common Stock and accompanying warrants to purchase 210,743 shares of Common Stock. The combined purchase price in the Offering was $1.50 per share of Common Stock and accompanying warrant. |
F2 | Shares held by Flagship Fund V. Flagship Ventures Fund V General Partner LLC ("Flagship V GP") is the general partner of Flagship Fund V. Noubar B. Afeyan, Ph.D. is the sole manager of Flagship V GP. Each of the reporting persons except for Flagship Fund V disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein. |
F3 | Shares held by Flagship Fund V Rx. Flagship V GP is the general partner of Flagship Fund V Rx. Noubar B. Afeyan, Ph.D. is the sole manager of Flagship V GP. Each of the reporting persons except for Flagship Fund V Rx disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein. |
F4 | Shares held by Flagship VentureLabs V LLC ("VentureLabs V"). Flagship VentureLabs V Manager LLC ("VentureLabs V Manager") is the manager of VentureLabs V. Flagship Pioneering, Inc. ("Flagship Pioneering") is the manager of VentureLabs V Manager. Noubar B. Afeyan, Ph.D. is the CEO and sole stockholder of Flagship Pioneering. Each of the reporting persons except for VentureLabs V disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein. |